Literature DB >> 28392297

Group II metabotropic glutamate receptor interactions with NHERF scaffold proteins: Implications for receptor localization in brain.

Stefanie L Ritter-Makinson1, Maryse Paquet1, James W Bogenpohl2, Rachel E Rodin1, C Chris Yun3, Edward J Weinman4, Yoland Smith5, Randy A Hall6.   

Abstract

The group II metabotropic glutamate receptors mGluR2 and mGluR3 are key modulators of glutamatergic neurotransmission. In order to identify novel Group II metabotropic glutamate receptor (mGluR)-interacting partners, we screened the C-termini of mGluR2 and mGluR3 for interactions with an array of PDZ domains. These screens identified the Na+/H+ exchanger regulatory factors 1 and 2 (NHERF-1 & -2) as candidate interacting partners. Follow-up co-immunoprecipitation studies demonstrated that both mGluR2 and mGluR3 can associate with NHERF-1 and NHERF-2 in a cellular context. Functional studies revealed that disruption of PDZ interactions with mGluR2 enhanced receptor signaling to Akt. However, further studies of mGluR2 and mGluR3 signaling in astrocytes in which NHERF expression was reduced by gene knockout (KO) and/or siRNA knockdown techniques revealed that the observed differences in signaling between WT and mutant mGluR2 were likely not due to disruption of interactions with the NHERF proteins. Electron microscopic analyses revealed that Group II mGluRs were primarily expressed in glia and unmyelinated axons in WT, NHERF-1 and NHERF-2 KO mice, but the relative proportion of labeled axons over glial processes was higher in NHERF-2 KO mice than in controls and NHERF-1 KO mice. Interestingly, our anatomical studies also revealed that loss of either NHERF protein results in ventriculomegaly, which may be related to the high incidence of hydrocephaly that has previously been observed in NHERF-1 KO mice. Together, these studies support a role for NHERF-1 and NHERF-2 in regulating the distribution of Group II mGluRs in the murine brain, while conversely the effects of the mGluR2/3 PDZ-binding motifs on receptor signaling are likely mediated by interactions with other PDZ scaffold proteins beyond the NHERF proteins.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  astrocyte; axon; electron microscopy; knockout mice; pre-synaptic; protein–protein interaction

Mesh:

Substances:

Year:  2017        PMID: 28392297      PMCID: PMC5503475          DOI: 10.1016/j.neuroscience.2017.03.060

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  71 in total

1.  GLAST stability and activity are enhanced by interaction with the PDZ scaffold NHERF-2.

Authors:  Stefanie L Ritter; Matthew J Asay; Maryse Paquet; Kevin J Paavola; Rachel E Reiff; C Chris Yun; Randy A Hall
Journal:  Neurosci Lett       Date:  2010-04-27       Impact factor: 3.046

2.  N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells.

Authors:  B Wroblewska; J T Wroblewski; S Pshenichkin; A Surin; S E Sullivan; J H Neale
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

3.  Group II metabotropic glutamate receptors in anxiety circuitry: correspondence of physiological response and subcellular distribution.

Authors:  E Chris Muly; Irakli Mania; Ji-Dong Guo; Donald G Rainnie
Journal:  J Comp Neurol       Date:  2007-12-20       Impact factor: 3.215

Review 4.  Metabotropic glutamate receptors as drug targets: what's new?

Authors:  Ferdinando Nicoletti; Valeria Bruno; Richard Teke Ngomba; Roberto Gradini; Giuseppe Battaglia
Journal:  Curr Opin Pharmacol       Date:  2014-12-12       Impact factor: 5.547

5.  LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors.

Authors:  D D Schoepp; B G Johnson; R A Wright; C R Salhoff; N G Mayne; S Wu; S L Cockerman; J P Burnett; R Belegaje; D Bleakman; J A Monn
Journal:  Neuropharmacology       Date:  1997-01       Impact factor: 5.250

6.  Cyclic AMP-dependent protein kinase phosphorylates group III metabotropic glutamate receptors and inhibits their function as presynaptic receptors.

Authors:  Z Cai; J A Saugstad; S D Sorensen; K J Ciombor; C Zhang; H Schaffhauser; F Hubalek; J Pohl; R M Duvoisin; P J Conn
Journal:  J Neurochem       Date:  2001-08       Impact factor: 5.372

Review 7.  Metabotropic glutamate receptors as therapeutic targets for schizophrenia.

Authors:  Paige N Vinson; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2011-05-19       Impact factor: 5.250

8.  Cystic fibrosis transmembrane conductance regulator activation is reduced in the small intestine of Na+/H+ exchanger 3 regulatory factor 1 (NHERF-1)- but Not NHERF-2-deficient mice.

Authors:  Nellie Broere; Jutta Hillesheim; Biguang Tuo; Huub Jorna; Adriaan B Houtsmuller; Shirish Shenolikar; Edward J Weinman; Mark Donowitz; Ursula Seidler; Hugo R de Jonge; Boris M Hogema
Journal:  J Biol Chem       Date:  2007-10-18       Impact factor: 5.157

9.  Abnormal development of NG2+PDGFR-α+ neural progenitor cells leads to neonatal hydrocephalus in a ciliopathy mouse model.

Authors:  Calvin S Carter; Timothy W Vogel; Qihong Zhang; Seongjin Seo; Ruth E Swiderski; Thomas O Moninger; Martin D Cassell; Daniel R Thedens; Kim M Keppler-Noreuil; Peggy Nopoulos; Darryl Y Nishimura; Charles C Searby; Kevin Bugge; Val C Sheffield
Journal:  Nat Med       Date:  2012-11-18       Impact factor: 53.440

10.  Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice.

Authors:  Louisa Lyon; James N C Kew; Corrado Corti; Paul J Harrison; Philip W J Burnet
Journal:  Synapse       Date:  2008-11       Impact factor: 2.562

View more
  1 in total

Review 1.  Metabotropic glutamate receptor trafficking.

Authors:  Young Ho Suh; Kai Chang; Katherine W Roche
Journal:  Mol Cell Neurosci       Date:  2018-03-29       Impact factor: 4.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.